Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma

The present study aimed to define high-risk patients who may benefit from additional adjuvant chemotherapy (AC) after concurrent chemotherapy in combination with intensity-modulated radiotherapy among patients with loco-regionally advanced nasopharyngeal carcinoma (NPC). A cohort of 511 NPC patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Zhong-Guo, Chen, Xiao-Qian, Lin, Guo-Xiang, Yu, Bin-Bin, Chen, Kai-Hua, Zhong, Qiu-Lu, Nong, Si-Kai, Li, Ling, Qu, Song, Su, Fang, Zhao, Wei, Li, Ye, Zhu, Xiao-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288719/
https://www.ncbi.nlm.nih.gov/pubmed/28150694
http://dx.doi.org/10.1038/srep41449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288719/
https://www.ncbi.nlm.nih.gov/pubmed/28150694
http://dx.doi.org/10.1038/srep41449

Ejemplares similares